Clinical Trial Update: Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) [Phase 3]

View source ↗

Summary

BEAT-MS is a Phase 3 trial comparing best available therapy to autologous hematopoietic stem cell transplantation for multiple sclerosis; it is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: RECRUITING